Similar articles

• Osteoporosis in health and disease: a dermatologist's perspective.

  Lamb A, Werth V. Lamb A, et al. Dermatol Clin. 2006 Apr;24(2):241-9, vii. doi: 10.1016/j.det.2006.01.013. Dermatol Clin. 2006. PMID: 16677970 Review.
• [Corticosteroids, osteoporosis and vitamin D. New and interesting results].

  Naess K. Naess K. Tidsskr Nor Laegeforen. 1976 Mar 30;96(9-10):589. Tidsskr Nor Laegeforen. 1976. PMID: 1258034 Norwegian. No abstract available.
• [Evaluation of the consequences of an erroneous treatment of nephrosis].

  Genova R, Canonaco F, Guerra A, Caracalla M. Genova R, et al. Pediatr Med Chir. 1981 Jan-Feb;3(1):77-85. Pediatr Med Chir. 1981. PMID: 7029489 Review. Italian. No abstract available.
• [Complications of long-term corticotherapy: how to prevent?].

  David L. David L. Pediatrie. 1989;44(2):73-6. Pediatrie. 1989. PMID: 2717337 French. No abstract available.
• Myasthenia gravis, corticosteroids and osteoporosis prophylaxis.

  Smith GD, Stevens DL, Fuller GN. Smith GD, et al. J Neurol. 2001 Feb;248(2):151. doi: 10.1007/s004150170254. J Neurol. 2001. PMID: 11284137 No abstract available.